Mir, R.H.;                     Mir, P.A.;                     Uppal, J.;                     Chawla, A.;                     Patel, M.;                     Bardakci, F.;                     Adnan, M.;                     Mohi-ud-din, R.    
        Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics. Metabolites 2023, 13, 509.
    https://doi.org/10.3390/metabo13040509
    AMA Style
    
                                Mir RH,                                 Mir PA,                                 Uppal J,                                 Chawla A,                                 Patel M,                                 Bardakci F,                                 Adnan M,                                 Mohi-ud-din R.        
                Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics. Metabolites. 2023; 13(4):509.
        https://doi.org/10.3390/metabo13040509
    
    Chicago/Turabian Style
    
                                Mir, Reyaz Hassan,                                 Prince Ahad Mir,                                 Jasreen Uppal,                                 Apporva Chawla,                                 Mitesh Patel,                                 Fevzi Bardakci,                                 Mohd Adnan,                                 and Roohi Mohi-ud-din.        
                2023. "Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics" Metabolites 13, no. 4: 509.
        https://doi.org/10.3390/metabo13040509
    
    APA Style
    
                                Mir, R. H.,                                 Mir, P. A.,                                 Uppal, J.,                                 Chawla, A.,                                 Patel, M.,                                 Bardakci, F.,                                 Adnan, M.,                                 & Mohi-ud-din, R.        
        
        (2023). Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics. Metabolites, 13(4), 509.
        https://doi.org/10.3390/metabo13040509